SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, has announced a $4 million registered direct offering priced at-the-market under Nasdaq rules. The company will issue and sell a total of 5,242,464 shares of its common stock at a purchase price of $0.763 per share. Additionally, in a concurrent private placement, SeaStar Medical will issue unregistered warrants to purchase up to 5,242,464 shares of common stock, with an exercise price of $0.638 per share. These warrants will be exercisable immediately and will expire five years from the effective date of the resale registration statement. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering, which is expected to close on or about July 10, 2025, subject to customary closing conditions. SeaStar Medical plans to use the net proceeds for general corporate purposes, including additions to working capital and capital expenditures.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.